We use cookies to provide you with a better experience. By continuing to browse the site you are agreeing to our use of cookies in accordance with our Cookie Policy.
Accept
Home » Clinical Hold on Corautus Genetics Trial Lifted
Clinical Hold on Corautus Genetics Trial Lifted
July 13, 2006
The FDA has partially lifted the clinical hold on Corautus Genetics’ GENASIS Phase IIb clinical trial of its VEGF-2 therapy for cardiovascular (severe angina) disease and peripheral vascular disease, the company said July 13.